Cargando…

Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination

BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Davuluri, Kusuma Sai, Singh, Amit Kumar, Yadav, Vimal Kumar, Singh, Ajay Vir, Singh, Shoor Vir, Chauhan, Devendra Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691138/
https://www.ncbi.nlm.nih.gov/pubmed/38036985
http://dx.doi.org/10.1186/s12865-023-00576-x
_version_ 1785152679199113216
author Davuluri, Kusuma Sai
Singh, Amit Kumar
Yadav, Vimal Kumar
Singh, Ajay Vir
Singh, Shoor Vir
Chauhan, Devendra Singh
author_facet Davuluri, Kusuma Sai
Singh, Amit Kumar
Yadav, Vimal Kumar
Singh, Ajay Vir
Singh, Shoor Vir
Chauhan, Devendra Singh
author_sort Davuluri, Kusuma Sai
collection PubMed
description BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections. MATERIALS AND METHODS: In this study, we administered Xpro-1595 to guinea pigs to selectively inhibit solTNF, aiming to assess its impact on Mycobacterium tuberculosis (M.tb) dissemination, bacterial growth attenuation, and immunological responses. We conducted immunohistochemical analyses, immunological assays, and colony enumeration to comprehensively study the effects of Xpro-1595 by comparing with anti-TB drugs treated M.tb infected guinea pigs. Throughout the infection and treatment period, we measured the levels of Interleukin-12 subunit alpha (IL-12), Interferon-gamma (IFN-γ), TNF, Tumor growth factor (TGF), and T lymphocytes using ELISA. RESULTS: Our findings revealed a reduction in M.tb dissemination and inflammation without compromising the immune response during Xpro-1595 treatment. Notably, Xpro-1595 therapy effectively regulated the expression of VEGFA and ELR + chemokines, which emerged as key factors contributing to infection dissemination. Furthermore, this treatment influenced the migration of CD4 T cells in the early stages of infection, subsequently leading to a reduced T cell response and controlled proinflammatory signalling, thus mitigating inflammation. CONCLUSION: Our study underscores the pivotal role of solTNF in the dissemination of M.tb to other organs. This preliminary investigation sheds light on the involvement of solTNF in the mechanisms underlying M.tb dissemination, although further in-depth research is warranted to fully elucidate its role in this process.
format Online
Article
Text
id pubmed-10691138
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106911382023-12-02 Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination Davuluri, Kusuma Sai Singh, Amit Kumar Yadav, Vimal Kumar Singh, Ajay Vir Singh, Shoor Vir Chauhan, Devendra Singh BMC Immunol Research BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections. MATERIALS AND METHODS: In this study, we administered Xpro-1595 to guinea pigs to selectively inhibit solTNF, aiming to assess its impact on Mycobacterium tuberculosis (M.tb) dissemination, bacterial growth attenuation, and immunological responses. We conducted immunohistochemical analyses, immunological assays, and colony enumeration to comprehensively study the effects of Xpro-1595 by comparing with anti-TB drugs treated M.tb infected guinea pigs. Throughout the infection and treatment period, we measured the levels of Interleukin-12 subunit alpha (IL-12), Interferon-gamma (IFN-γ), TNF, Tumor growth factor (TGF), and T lymphocytes using ELISA. RESULTS: Our findings revealed a reduction in M.tb dissemination and inflammation without compromising the immune response during Xpro-1595 treatment. Notably, Xpro-1595 therapy effectively regulated the expression of VEGFA and ELR + chemokines, which emerged as key factors contributing to infection dissemination. Furthermore, this treatment influenced the migration of CD4 T cells in the early stages of infection, subsequently leading to a reduced T cell response and controlled proinflammatory signalling, thus mitigating inflammation. CONCLUSION: Our study underscores the pivotal role of solTNF in the dissemination of M.tb to other organs. This preliminary investigation sheds light on the involvement of solTNF in the mechanisms underlying M.tb dissemination, although further in-depth research is warranted to fully elucidate its role in this process. BioMed Central 2023-11-30 /pmc/articles/PMC10691138/ /pubmed/38036985 http://dx.doi.org/10.1186/s12865-023-00576-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Davuluri, Kusuma Sai
Singh, Amit Kumar
Yadav, Vimal Kumar
Singh, Ajay Vir
Singh, Shoor Vir
Chauhan, Devendra Singh
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title_full Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title_fullStr Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title_full_unstemmed Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title_short Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
title_sort dominant negative biologics normalise the tumour necrosis factor (tnf-α) induced angiogenesis which exploits the mycobacterium tuberculosis dissemination
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691138/
https://www.ncbi.nlm.nih.gov/pubmed/38036985
http://dx.doi.org/10.1186/s12865-023-00576-x
work_keys_str_mv AT davulurikusumasai dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination
AT singhamitkumar dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination
AT yadavvimalkumar dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination
AT singhajayvir dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination
AT singhshoorvir dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination
AT chauhandevendrasingh dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination